WuXi PharmaTech (Cayman) Inc. Accounts Receivable, Credit Loss Expense (Reversal)
WuXi PharmaTech (Cayman) Inc. reported Accounts Receivable, Credit Loss Expense (Reversal) of $10.00 thousand for the 12-month period ending 2010-12-31, per its 20-F filed 2011-04-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2011-04-27
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|
| 2010-12-31 | $10.00K 20-F · filed 2011-04-27 |
| 2009-12-31 | $1.61M 20-F · filed 2011-04-27 |
| 2008-12-31 | -$665.00K 20-F · filed 2011-04-27 |